Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.37 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.35 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | B4GALT1 | P15291 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 4/20 | 0.33 |
| ▸ | TLR1 | Q15399 | 4/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7152277 | 1.00 | L3MBTL1 (0.55) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL10488689 | 1.00 | L3MBTL1 (0.55) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL8831098 | 0.91 | L3MBTL1 (0.56) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL11094885 | 0.91 | L3MBTL1 (0.51) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL11419924 | 0.89 | KMT2A (0.62) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL9472687 | 0.89 | KMT2A (0.62) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL15508270 | 0.88 | L3MBTL1 (0.59) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL10333863 | 0.87 | L3MBTL1 (0.54) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL14355283 | 0.87 | L3MBTL1 (0.54) | L3MBTL1KMT2AMEN1ALDH1A1PKM | |
| SCHEMBL14355284 | 0.86 | L3MBTL1 (0.56) | L3MBTL1KMT2AMEN1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023194941-A1 | LARGE SCALE PRODUCTION OF N-ACETYLLACTOSAMINE DERIVATIVES | KODE BIOTECH LIMITED (NZ) | 2023-10-12 | — | — | WO | disclosed |
| US-6562514-B1 | Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries | PINNACLE VRB LIMITED (AU) | 2003-05-13 | — | — | US | disclosed |
| US-6468688-B2 | CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE | PINNACLE VRB LIMITED (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-5939290-A | Modified sialyl Lewisx compounds | ALBERTA RESEARCH COUNCIL (CA) | 1999-08-17 | — | — | US | disclosed |
| US-5882901-A | SIALYLATING SPECIFIED OLIGOSACCHARIDE WITH SIALYLTRANSFERASE, FUCOSYLATING WITH FUCOSYLTRANSFERASE | ALBERTA RESEARCH COUNCIL (CA) | 1999-03-16 | — | — | US | disclosed |
| US-5874411-A | ANTIINFLAMMATORY | GLYCOMED INCORPORATED (US) | 1999-02-23 | — | — | US | disclosed |
| US-5872096-A | MODULATION OF A CELL MEDIATED IMMUNE RESPONSE, USED TO PREPARE ARTIFICIAL ANTIGENS FOR THE GENERATION OF MONOCLONAL OR POLYCLONAL ANTIBODIES | ALBERTA RESEARCH COUNCIL (CA) | 1999-02-16 | — | — | US | disclosed |
| US-5759993-A | OLIGOSACCHARIDES AS IMMUNOMODULATORS | ALBERTA RESEARCH COUNCIL (CA) | 1998-06-02 | — | — | US | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| US-5654412-A | CONVERGENT SYNTHESIS VIA TWO DISACCHARIDE SUBCOMPONENTS; SIMPLIFICATION, HIGH YIELD | GLYCOMED INCORPORATED (US) | 1997-08-05 | — | — | US | disclosed |
| US-5646123-A | Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen | ALBERTA RESEARCH COUNCIL (CA) | 1997-07-08 | — | — | US | disclosed |
| US-5580858-A | Immunosuppressive and tolerogenic modified Lewisx compounds | ALBERTA RESEARCH COUNCIL (CA) | 1996-12-03 | — | — | US | disclosed |
| WO-1993024505-A1 | REDUCING INFLAMMATION BY TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDES GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS | ALBERTA RESEARCH COUNCIL (CA) | 1993-12-09 | — | — | WO | disclosed |
| US-4238473-A | LOWER CARBOHYDRATES HAVING A BRIDGING ARM GLYCOSIDICALLY LINKED TO AN ALDOSE MOIETY | CHEMBIOMED LIMITED (CA) | 1980-12-09 | — | — | US | disclosed |
| US-4137401-A | Glycoside-ether-ester compounds | CHEMBIOMED LIMITED (CA) | 1979-01-30 | — | — | US | disclosed |